British Patient Capital has committed £10 million to Form3, an innovative British payment technology firm. This investment, part of Form3’s Series C funding extension, seeks to bolster the company’s capacity to scale operations, innovate new products, and widen its market reach. As financial institutions globally seek robust digital solutions, Form3’s cloud-native infrastructure offers an efficient platform for real-time payments, replacing outdated legacy systems. The strategic financial backing by British Patient Capital is expected to enhance Form3’s ability to facilitate digital transformations for major banks and financial entities, positioning them for future growth in the digital payments landscape.
Supporting Digital Innovation
In the past, Form3 has consistently attracted support from prestigious investors, including Visa and Molten, demonstrating its robust position in the fintech sector. The additional funding from British Patient Capital emphasizes confidence in Form3’s capacity to address the evolving needs of financial institutions. Over the years, the company’s platform has enabled many banks to seamlessly transition to digital payment methods. Recent investments further signal a commitment to advancing this technological evolution, benefiting stakeholders involved in the digital finance ecosystem.
Aligning with Strategic Goals
British Patient Capital, a subsidiary of the UK government’s British Business Bank, focuses on long-term investments in innovative firms. With a portfolio exceeding £3 billion, it empowers ambitious entrepreneurs to scale their operations. The recent investment in Form3 aligns with British Patient Capital’s mission to support high-growth potential businesses in accessing necessary funding. Its strategic support aims to foster the growth of Form3’s scalable platform and solidify its presence in the competitive payment technology industry.
British Patient Capital’s Managing Director, Tom Haywood, acknowledged the strategic nature of the investment, stating,
“Form3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure. We are delighted to support them as they take the next steps in their growth journey.”
Similarly, Form3’s CFO, Benyam Hagos, highlighted the investment’s significance, noting,
“British Patient Capital’s investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world’s most established banks and financial institutions.”
The partnership between Form3 and British Patient Capital underscores an increasing focus on developing advanced payment technologies to cater to global financial institutions. This collaboration reflects a broader industry trend of prioritizing seamless, real-time digital payment infrastructure. As Form3 continues to leverage British Patient Capital’s investment, it will be crucial for stakeholders to monitor how these enhancements influence the broader financial sector. The support of such significant investors indicates a promising trajectory for Form3, potentially spurring further technological advancements and market expansion in the payment technology landscape.
